Follicular lymphoma Follicular lymphoma
Conditions
Interventions
Only registered products are used during this study. Radiopharmaceutical F-fluor-2 -deoxy-glucose (FDG) PET/CT imaging is performed by standard operating procedures at the Amsterdam UMC. The patient i
Sponsors
Amsterdam UMC
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 18 years and older Able to remain supine for at least 20 minutes in the PET/CT scanner Able to give a written and signed informed consent Follicular lymphoma grade between 1 and 3A Follicular lymphoma with Ann-Arbor stage 2-4 In “watch and wait” after diagnosis of follicular lymphoma
Exclusion criteria
Exclusion criteria: - Claustrophobic patients - Pregnant and breastfeeding patients - Uncontrolled diabetes mellitus - Any medical condition potentially hampering conduction of the study - Any other contraindication to undergo an FDG PET/CT examination - Previously treated for lymphoma - Participation in other research trials that can influence the progression of the disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the time to treatment (TTT) and the collection of PET/CT data for radiomics analysis during the W&W period of patients with FL. The TTT is defined as the time from diagnosis until the initiation of first therapy. The main endpoint for the study is 24 months after inclusion of the last patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| N.A. | — |
Countries
Netherlands
Contacts
Public ContactJ. M. Zijlstra
Amsterdam UMC
Outcome results
None listed